Tag: solid tumor testing market insights

  • Comprehensive Solid Tumor Testing Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Solid Tumor Testing Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Growth Rate Can Be Expected in the Solid Tumor Testing Market from 2024 Through 2033?

    In the past few years, the solid tumor testing market has seen robust growth. It’s projected to increase from $25.74 billion in 2023 to $27.78 billion in 2024, with a compound annual growth rate (CAGR) of 7.9%. The significant growth observed in the historical period can be credited to factors such as personalized or precision medicine, the inefficiency of tumor-selective drug delivery, low therapeutic efficacy, high costs that are not sustainable, and the simplistic approaches to cancer chemotherapies.

    The market size for solid tumor testing is anticipated to experience robust expansion in the forthcoming years. It is estimated to soar to $36.48 billion by 2028, growing at a compound annual growth rate (CAGR) of 7.1%. This acceleration during the forecast period is linked to an increased incidence of cancer, an expanded healthcare infrastructure, the rise of AI and IoT-based diagnostic appliances, and enhanced government initiatives. Notable trends for the forecast period consist of evolving diagnostic tools, the advent of nanocarrier-based treatments, strategical alliances and the innovation of next-generation testing equipment.

    Claim Your Free Sample of the Global Solid Tumor Testing Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12658&type=smp

    What Dynamics Are Shaping the Growth of the solid tumor testing Market?

    Due to the growing incidence of cancer, the solid tumor testing market is predicted to expand. Cancer, characterized by uncontrolled growth and spread of abnormal cells, can affect nearby tissues and organs and sometimes migrates to other body parts via the bloodstream or lymphatic system. Solid tumors account for around 90% of adult cancers. Solid tumor testing employs the identification of cancerous cells in the blood of patients diagnosed with solid tumors, even in instances where the cancer is yet to be confirmed via imaging tests. For example, in June 2023, the Centers for Disease Control and Prevention reported that in 2020, there were 1,603,844 new cancer cases and 602,347 cancer-related fatalities in the US. Also, for every 100,000 persons, about 403 new cancer cases and 144 cancer-related deaths were accounted for. This surge in cancer prevalence is, therefore, giving an upward push to the growth of the solid tumor testing market.

    What Are the Essential Segments of the Solid Tumor Testing Market?

    1) By Type: Genetic Testing, Conventional Testing

    2) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer

    3) By Application: Clinical, Research

    4) By End-Users: Hospitals, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic Research Institutions

    What Are the Defining Trends in the Evolving Solid Tumor Testing Market?

    Advancements in liquid biopsy test solutions are an emerging trend in the field of solid tumor testing. These solutions are being developed to solidify the position of top tier companies and give them a competitive edge in the market. For instance, NeoGenomics Inc., an American testing laboratory, unveiled a series of three liquid biopsy tests for solid tumors in June 2020. These cutting-edge tests have the capacity to pinpoint cancer cells in a patient’s bloodstream, even before they become detectable in imaging tests. They act as a guide for physicians in determining the next steps of testing or treatment. What sets them apart is their non-invasive nature, ability for early detection, customizable treatment, and FDA approval. Furthermore, these tests have a turnaround time of less than a week, effectively saving a substantial amount of time for clinicians.

    Order Now for Fast Delivery of Your Solid Tumor Testing Market Report!

    https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

    Which Regions Are Emerging as Leaders in the Solid Tumor Testing Market?

    North America was the largest region in the solid tumor testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the solid tumor testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Solid Tumor Testing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the solid tumor testing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Solid Tumor Testing Market Include

    1. Solid Tumor Testing Market Executive Summary

    2. Solid Tumor Testing Market Segments

    3. Solid Tumor Testing Market Size And Template Market Growth Rate

    4. Key Solid Tumor Testing Market Trends

    5. Major Solid Tumor Testing Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Solid Tumor Testing Market

    26. Top Solid Tumor Testing Companies

    27. Solid Tumor Testing Market Opportunities And Strategies

    28. Solid Tumor Testing Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Pharmaceutical Sterility Testing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pharmaceutical-sterility-testings-global-market-report

    Cardiac Biomarkers Testing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report

    Respiratory Disease Testing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/respiratory-disease-testing-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Overview Of The Solid Tumor Testing Market 2024-2033: Growth And Major Players Analysis

    Overview Of The Solid Tumor Testing Market 2024-2033: Growth And Major Players Analysis

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

     

    Current Market Growth

    • Robust growth: From $25.74 billion in 2023 to $27.78 billion in 2024 (CAGR: 7.9%)
    • Factors driving historic growth: Personalized medicine, poor tumor-selective drug delivery, low therapeutic efficacy, unsustainable costs, reductionist approaches to cancer chemotherapies

    Future Growth Prospects

    • Strong growth expected to $36.48 billion in 2028 (CAGR: 7.1%)
    • Factors contributing to forecasted growth: Increasing cancer prevalence, healthcare infrastructure development, emergence of AI and IoT-based diagnostic devices, government initiatives
    • Major trends in the forecast period: Advancements in diagnostic tools, nanocarrier-based therapies, strategic collaborations, next-generation testing devices

    View More On The Solid Tumor Testing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/solid-tumor-testing-global-market-report

    Growing Cancer Prevalence Fuels Market Expansion

    • Impact of increasing cancer prevalence on market growth
    • Use of solid tumor testing in detecting cancer cells
    • Example: Cancer statistics in the US
    • Role of solid tumor testing in early detection and treatment decisions
    • Leading companies in the market

    Innovative Liquid Biopsy Tests Drive Market Growth

    • Significance of liquid biopsy test solutions in market trends
    • Development of innovative liquid biopsy tests by major companies
    • Example: NeoGenomics Inc.’s suite of liquid biopsy tests
    • Benefits of liquid biopsy tests: Non-invasiveness, early detection, personalized treatment
    • Strategic acquisitions to strengthen market position

    Strategic Acquisitions Propel Market Growth

    • Importance of strategic acquisitions in market expansion
    • Example: Quest Diagnostics’ acquisition of Haystack Oncology Inc.
    • Objectives of acquisitions: Expand access to technology, enhance research and development capabilities
    • Impact on market share and diagnostic capabilities
    • Market segmentation and regional insights

    Conclusion

    • The solid tumor testing market is witnessing significant growth driven by factors such as increasing cancer prevalence and advancements in diagnostic technologies.
    • Future growth prospects remain strong, with a focus on innovative solutions and strategic collaborations.
    • Companies in the market need to leverage emerging trends and opportunities to address the growing demand for effective cancer diagnostics and treatments worldwide.

    Request A Sample Of The Global Solid Tumor Testing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12658&type=smp